The current clinical practice is continuous long-termadministration of Stem cell mobilization, which can be complicated by adverseeffects. Alternatives to long-term use of Stem cell mobilization are being developed, such as combination therapies, permitting for limited duration therapy.
Novel mobilization regimens are under development, which differ fromPlerixafor, and therefore may differentiate themselves from Plerixafor in termsof adverse effects or efficacy.
The Stem Cell market is witnessing a growth in productdemand owing to various reasons, one of the key factors being the risingprevalence of various chronic diseases and the significant need for their drug discovery.
Do you know about Stem Cell Market Size
Cell transplantation as a therapy for neurodegenerative disorderssuch as Diabetes type 1, Parkinson's disease, and Alzheimer's disease amongothers are already being explored. For instance, in January 2022, the first patient in Canada has been dosed in a Phase 1 clinical trial of DA01, a cell-based investigational therapy for advanced Parkinson’s disease by BlueRock Therapeutics.
Based on the preclinical effect in these diseases, thetechnique is now being applied to other neurodegenerative disorders, such asAD, amyotrophic lateral sclerosis, and Huntington’s disease.
According to WHO, by 2020, the prevalence of the chronic disease is predicted to increase by 57%. As the prevalence of chronic disease increases, people opting for stemcell-based treatment will rise, thus driving the market growth.
Therefore, the prevalence of various chronic diseases and their research activities involved in drug development, in turn, would lead to an increase in demand for Stem Cell therapies in the forecast period (2021-2026), which will drive the Stem Cellmarket growth.
Are you aware about Stem Cell Marketplace
Latest Pharma Published Reports